The University of California, San Francisco Medical Center is a research and teaching hospital in San Francisco, California and is the medical center of the University of California, San Francisco. It is affiliated with the UCSF School of Medicine.

There are 796 beds in UCSF Medical Center-Parnassus.

During the past decade, UCSF Medical Center-Parnassus conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 58 clinical trials were completed, i.e. on average, 148.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 31 clinical trials were completed. i.e. 182.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UCSF Medical Center-Parnassus" #1 sponsor was "Children's Oncology Group" with 49 trials, followed by "National Cancer Institute (NCI)" with 45 trials sponsored, "University of California, San Francisco" with 7 trials sponsored, "AIDS Malignancy Consortium" with 4 trials sponsored and "Alliance for Clinical Trials in Oncology" with 4 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCSF Medical Center-Parnassus" #1 collaborator was "National Cancer Institute (NCI)" with 59 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Agenus Inc." with 1 trials as a collaborator and "BioFire Diagnostics, LLC" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "UCSF Medical Center-Parnassus" are "Recurrent Neuroblastoma" (9 trials), "Acute Lymphoblastic Leukemia" (8 trials), "Childhood B Acute Lymphoblastic Leukemia" (6 trials), "Gliosarcoma" (6 trials) and "HIV Infection" (6 trials). Many other conditions were trialed in "UCSF Medical Center-Parnassus" in a lesser frequency.

Most popular intervention types in "UCSF Medical Center-Parnassus" are "Drug" (88 trials), "Other" (84 trials), "Biological" (36 trials), "Procedure" (30 trials) and "Radiation" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (64 trials), "Cyclophosphamide" (27 trials), "Pharmacological Study" (25 trials), "Vincristine Sulfate" (23 trials) and "Etoposide" (20 trials). Other intervention names were less common.

The vast majority of trials in "UCSF Medical Center-Parnassus" are 118 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "UCSF Medical Center-Parnassus". 3 are not yet recruiting, 18 are recruiting, 42 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 55 completed trials in UCSF Medical Center-Parnassus, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UCSF Medical Center-Parnassus, 32 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".